Oncology firm Yellowstone Biosciences has chosen the ARC Oxford science campus as its first home.
The firm was spun out of the University of Oxford in June with support from Oxford University Innovation. It has launched with £16.5m secured in
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
